BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Janczewska-Kazek E, Marek B, Kajdaniuk D, Borgiel-Marek H. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-β1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C. World J Gastroenterol 2006; 12(6): 961-965 [PMID: 16521228 DOI: 10.3748/wjg.v12.i6.961]
URL: https://www.wjgnet.com/1007-9327/full/v12/i6/961.htm
Number Citing Articles
1
Shahab Mahmoudvand, Somayeh Shokri, Reza Taherkhani, Fatemeh Farshadpour. Hepatitis C virus core protein modulates several signaling pathways involved in hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(1): 42-58 doi: 10.3748/wjg.v25.i1.42
2
Nury M. Steuerwald, Judith C. Parsons, Kristen Bennett, Tonya C. Bates, Herbert L. Bonkovsky. Parallel microRNA and mRNA expression profiling of (genotype 1b) human hepatoma cells expressing hepatitis C virusLiver International 2010; 30(10): 1490 doi: 10.1111/j.1478-3231.2010.02321.x
3
Pavel Chalupa, Alžběta Davidová, Ondřej Beran, Simona Arientová, Pavel Boštík, Jaroslav Kapla, Kateřina Kondělková, Stanislav Plíšek, Michal Holub. Effect of antiviral treatment of chronic hepatitis C on the frequency of regulatory T cells, T‐cell activation, and serum levels of TGF‐betaAPMIS 2016; 124(8): 711 doi: 10.1111/apm.12561
4
Alessia Virzì, Armando Andres Roca Suarez, Thomas F. Baumert, Joachim Lupberger. Rewiring Host Signaling: Hepatitis C Virus in Liver PathogenesisCold Spring Harbor Perspectives in Medicine 2020; 10(1): a037366 doi: 10.1101/cshperspect.a037366
5
Andrew Caraganis, Susanna Benn, Merit Cudkowicz, Robert H. Brown. Thrombopoietin is ineffective in a mouse model of motor neuron diseaseAmyotrophic Lateral Sclerosis 2008; 9(6): 354 doi: 10.1080/17482960802103040
6
Hiroshi Yokoyama, Takahiro Masaki, Ikuyo Inoue, Mariko Nakamura, Yoshihiro Mezaki, Chisato Saeki, Tsunekazu Oikawa, Masayuki Saruta, Hiroyuki Takahashi, Masahiro Ikegami, Hiroshi Hano, Kenichi Ikejima, Soichi Kojima, Tomokazu Matsuura. Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver diseaseHeliyon 2019; 5(2): e01231 doi: 10.1016/j.heliyon.2019.e01231
7
G. Tarantino, A. Coppola, P. Conca, E. Cimino, G. Di Minno. Can Serum TGF-BETA 1 Be Used to Evaluate the Response to Antiviral Therapy of Haemophilic Patients with HCV-Related Chronic Hepatitis ?International Journal of Immunopathology and Pharmacology 2008; 21(4): 1007 doi: 10.1177/039463200802100426
8
Gianluigi Giannelli, Antonio Mazzocca, Emilia Fransvea, Michael Lahn, Salvatore Antonaci. Inhibiting TGF-β signaling in hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2011; 1815(2): 214 doi: 10.1016/j.bbcan.2010.11.004
9
Daniel Sepulveda-Crespo, Salvador Resino, Isidoro Martinez. Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver FibrosisDrugs 2021; 81(4): 419 doi: 10.1007/s40265-020-01458-x
10
Laura Cisneros, Maria-Carlota Londoño, Carmen Blasco, Ramón Bataller, Rosa Miquel, Miquel Bruguera, Pere Ginès, Antoni Rimola. Hepatic stellate cell activation in liver transplant patients with hepatitis C recurrence and in non-transplanted patients with chronic hepatitis CLiver Transplantation 2007; 13(7): 1017 doi: 10.1002/lt.21178
11
Jorge Pereira da Silva, Moisés Batista da Silva, Simone Rodrigues Campelo, Ubirajara Imbiriba Salgado, José Antonio Picanço Diniz, Philippe Esterre, Sonia Rozental, Claudio Guedes Salgado. TGF-β plasma levels in chromoblastomycosis patients during itraconazole treatmentCytokine 2010; 51(2): 202 doi: 10.1016/j.cyto.2010.05.004
12
Umberto Vespasiani-Gentilucci, Giovanni Galati, Chiara Mazzarelli, Delia D'Avola, Sandro Spataro, Paolo Gallo, Amelia Rigon, Adriano Pellicelli, Giordano Dicuonzo, Antonella Afeltra, Antonio Picardi. Angiogenic Cytokines in Patients Undergoing Antiviral Treatment for Chronic Hepatitis C Virus InfectionJournal of Interferon & Cytokine Research 2011; 31(2): 207 doi: 10.1089/jir.2010.0040